166 related articles for article (PubMed ID: 36326914)
1. N
Tang B; Li M; Xu Y; Li X
J Cancer Res Clin Oncol; 2023 Jul; 149(8):5037-5045. PubMed ID: 36326914
[TBL] [Abstract][Full Text] [Related]
2. KIAA1429 regulates cell proliferation by targeting c-Jun messenger RNA directly in gastric cancer.
Miao R; Dai CC; Mei L; Xu J; Sun SW; Xing YL; Wu LS; Wang MH; Wei JF
J Cell Physiol; 2020 Oct; 235(10):7420-7432. PubMed ID: 32052427
[TBL] [Abstract][Full Text] [Related]
3. m
Zhu Z; Zhou Y; Chen Y; Zhou Z; Liu W; Zheng L; Pei Q; Tan F; Pei H; Li Y
Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291811
[TBL] [Abstract][Full Text] [Related]
4. HNRNPA2B1-mediated m6A modification of FOXM1 promotes drug resistance and inhibits ferroptosis in endometrial cancer via regulation of LCN2.
Jiang J; Zhu J; Qiu P; Ni J; Zhu W; Wang X
Funct Integr Genomics; 2023 Dec; 24(1):3. PubMed ID: 38091112
[TBL] [Abstract][Full Text] [Related]
5. Annexin A1 induces oxaliplatin resistance of gastric cancer through autophagy by targeting PI3K/AKT/mTOR.
Ren J; Hu Z; Niu G; Xia J; Wang X; Hong R; Gu J; Wang D; Ke C
FASEB J; 2023 Mar; 37(3):e22790. PubMed ID: 36786694
[TBL] [Abstract][Full Text] [Related]
6. The FOXM1-induced resistance to oxaliplatin is partially mediated by its novel target gene Mcl-1 in gastric cancer cells.
Hu CJ; Wang B; Tang B; Chen BJ; Xiao YF; Qin Y; Yong X; Luo G; Zhang JW; Zhang D; Li S; He F; Yang SM
Biochim Biophys Acta; 2015 Mar; 1849(3):290-9. PubMed ID: 25482013
[TBL] [Abstract][Full Text] [Related]
7. m
Yang D; Chang S; Li F; Ma M; Yang J; Lv X; Huangfu L; Jia C
IUBMB Life; 2021 Nov; 73(11):1325-1333. PubMed ID: 34409730
[TBL] [Abstract][Full Text] [Related]
8. METase/lncRNA HULC/FoxM1 reduced cisplatin resistance in gastric cancer by suppressing autophagy.
Xin L; Zhou Q; Yuan YW; Zhou LQ; Liu L; Li SH; Liu C
J Cancer Res Clin Oncol; 2019 Oct; 145(10):2507-2517. PubMed ID: 31485766
[TBL] [Abstract][Full Text] [Related]
9. KIAA1429 contributes to liver cancer progression through N6-methyladenosine-dependent post-transcriptional modification of GATA3.
Lan T; Li H; Zhang D; Xu L; Liu H; Hao X; Yan X; Liao H; Chen X; Xie K; Li J; Liao M; Huang J; Yuan K; Zeng Y; Wu H
Mol Cancer; 2019 Dec; 18(1):186. PubMed ID: 31856849
[TBL] [Abstract][Full Text] [Related]
10. FOXM1/DVL2/Snail axis drives metastasis and chemoresistance of colorectal cancer.
Yang Y; Jiang H; Li W; Chen L; Zhu W; Xian Y; Han Z; Yin L; Liu Y; Wang Y; Pan K; Zhang K
Aging (Albany NY); 2020 Dec; 12(23):24424-24440. PubMed ID: 33291076
[TBL] [Abstract][Full Text] [Related]
11. The long non-coding RNA DDX11-AS1 facilitates cell progression and oxaliplatin resistance via regulating miR-326/IRS1 axis in gastric cancer.
Song W; Qian Y; Zhang MH; Wang H; Wen X; Yang XZ; Dai WJ
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3049-3061. PubMed ID: 32271422
[TBL] [Abstract][Full Text] [Related]
12. Gene amplification-driven RNA methyltransferase KIAA1429 promotes tumorigenesis by regulating BTG2 via m6A-YTHDF2-dependent in lung adenocarcinoma.
Zhang C; Sun Q; Zhang X; Qin N; Pu Z; Gu Y; Yan C; Zhu M; Dai J; Wang C; Li N; Jin G; Ma H; Hu Z; Zhang E; Tan F; Shen H
Cancer Commun (Lond); 2022 Jul; 42(7):609-626. PubMed ID: 35730068
[TBL] [Abstract][Full Text] [Related]
13. METTL3 promotes oxaliplatin resistance of gastric cancer CD133+ stem cells by promoting PARP1 mRNA stability.
Li H; Wang C; Lan L; Yan L; Li W; Evans I; Ruiz EJ; Su Q; Zhao G; Wu W; Zhang H; Zhou Z; Hu Z; Chen W; Oliveira JM; Behrens A; Reis RL; Zhang C
Cell Mol Life Sci; 2022 Feb; 79(3):135. PubMed ID: 35179655
[TBL] [Abstract][Full Text] [Related]
14. Gastric cancer mesenchymal stem cells promote tumor glycolysis and chemoresistance by regulating B7H3 in gastric cancer cells.
Gao Q; Huang C; Liu T; Yang F; Chen Z; Sun L; Zhao Y; Wang M; Luo L; Zhou C; Zhu W
J Cell Biochem; 2024 Mar; 125(3):e30521. PubMed ID: 38226525
[TBL] [Abstract][Full Text] [Related]
15. Circular RNA circ_0032821 contributes to oxaliplatin (OXA) resistance of gastric cancer cells by regulating SOX9 via miR-515-5p.
Zhong Y; Wang D; Ding Y; Tian G; Jiang B
Biotechnol Lett; 2021 Feb; 43(2):339-351. PubMed ID: 33123829
[TBL] [Abstract][Full Text] [Related]
16. N6-methyladenosine reader hnRNPA2B1 recognizes and stabilizes NEAT1 to confer chemoresistance in gastric cancer.
Wang J; Zhang J; Liu H; Meng L; Gao X; Zhao Y; Wang C; Gao X; Fan A; Cao T; Fan D; Zhao X; Lu Y
Cancer Commun (Lond); 2024 Apr; 44(4):469-490. PubMed ID: 38512764
[TBL] [Abstract][Full Text] [Related]
17. PARI functions as a new transcriptional target of FOXM1 involved in gastric cancer development.
Zhang Y; Ye X; Chen L; Wu Q; Gao Y; Li Y
Int J Biol Sci; 2018; 14(5):531-541. PubMed ID: 29805304
[TBL] [Abstract][Full Text] [Related]
18. Circular RNA circLRCH3 promotes oxaliplatin resistance in gastric cancer through the modulation of the miR-383-5p/FGF7 axis.
Xiang C; Li R; Qiu H; Zuo E; Zhang Y; Shan L; Cheng X
Histol Histopathol; 2023 Jun; 38(6):647-658. PubMed ID: 35920365
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of forkhead box M1 transcription factor (FOXM1) is a potential prognostic marker and enhances chemoresistance for docetaxel in gastric cancer.
Okada K; Fujiwara Y; Takahashi T; Nakamura Y; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Mori M; Doki Y
Ann Surg Oncol; 2013 Mar; 20(3):1035-43. PubMed ID: 23054116
[TBL] [Abstract][Full Text] [Related]
20. The m6A Methyltransferase METTL3-Mediated N6-Methyladenosine Modification of DEK mRNA to Promote Gastric Cancer Cell Growth and Metastasis.
Zhang HM; Qi FF; Wang J; Duan YY; Zhao LL; Wang YD; Zhang TC; Liao XH
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]